[1] |
HU Haipeng, YAO Weijie, FENG Xin.
Effects of Yangxue Antai Prescription on Placental Ferroptosis in Recurrent Spontaneous Abortion Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 621-626.
|
[2] |
XIE Ziyue, WANG Chengxiang, HU Yanpeng, LI Lei, CUI Herong.
Clinical Medications and Safety Analysis of Traditional Chinese Medicine for Post-Infection Cough
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 507-512.
|
[3] |
ZHOU Kun, MA Liang, LI Zhaofeng, CAO Bing, GU Hongwei, LIU Qian.
Usage of Nerve-Calming Chinese Herbal Patent Medicines in a Mental Health Center
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 211-216.
|
[4] |
SUN Li, XIE Bin, XU Yanqin.
Research progress of sustained and controlled release preparations of Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 949-954.
|
[5] |
YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin.
Roles of Yangxue Antai prescription in improving endometrial epithelial-mesenchymal transformation and decidualization in recurrent spontaneous abortion mice by regulating autophagy
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 547-552.
|
[6] |
LI Yao, CHEN Yuxin, GAO Haiyun, LI Hui, LIU Tianrui, YUAN Yuan.
Analysis of prescription rules for Omphalia lapidescens based on the Dictionary of Chinese Traditional Medicine Prescriptions
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 553-558.
|
[7] |
YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin.
Effect of Yangxue Antai prescription on the regulation of placental angiogenesis and autophagy in recurrent spontaneous abortion mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 371-377.
|
[8] |
YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin.
Study on the mechanism of Yangxue Antai prescription regulating autophagy in the treatment of recurrent spontaneous abortion mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 378-385.
|
[9] |
LIU Jie, ZHANG Jianmin, ZHANG Xiaomeng, LIU Fang, SONG Yuan, ZHONG Xuli.
Management of risks to pediatric medications based on drug instructions of Chinese patent medicines in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 422-427.
|
[10] |
ZHOU Yue, LIU Shuo, SONG Haibo.
Roles of licensed pharmacists in drug classification management
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 428-434.
|
[11] |
BAI Xue, CHEN Yafei, TANG Tian, LIU Zhejun, TAN Tianyang, LIU Zhenquan.
Research Progress on the Potential Therapeutic Effect of Bushen Shengjing Prescription on Oligoasthenozoospermia
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1243-1249.
|
[12] |
LI Yiwen, CAO Keming, LAN Yuze, SU Shuang, MA Hongliang, ZHANG Lili, CHANG Xiaohong, LI Bo.
Rational Use of Traditional Chinese Medicine Decoction Pieces in Outpatient Clinic of a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1293-1298.
|
[13] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[14] |
SU Yuefen, ZHENG Jingrou, GONG He, XIE Guangtong, ZHANG Jie, SAI Chunmei.
Formability and mechanism of breast nodule pain-alleviating gel plaster for the treatment of breast hyperplasia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 783-790.
|
[15] |
ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong.
Pharmacist-led practice in the management of elderly patients with polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.
|